Activity ID
15058Expires
July 7, 2029Format Type
EnduringCME Credit
1.00Fee
$0CME Provider: Massachusetts Medical Society
Description of CME Course
Prostate cancer screening remains one of the most challenging areas of preventive care, requiring clinicians to balance the potential benefits of early cancer detection against the risks of unnecessary testing, biopsy, and treatment. As advances in prostate imaging and risk assessment reshape clinical practice, primary care clinicians need practical approaches for evaluating elevated PSA levels and counseling patients about their options.
This activity examines how the prostate cancer screening landscape has evolved in the era of prostate MRI and active surveillance. Faculty will discuss emerging approaches that help distinguish clinically significant prostate cancer from benign conditions that commonly affect aging men, while highlighting strategies to reduce unnecessary interventions without compromising patient outcomes.
Through a review of contemporary evidence and real-world clinical scenarios, participants will gain greater confidence in navigating screening conversations, interpreting diagnostic findings, and making patient-centered decisions that reflect current standards of care.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Allergy and Immunology
Anesthesiology
Colon and Rectal Surgery
Family Medicine
Medical Genetics and Genomics
Nuclear Medicine
Ophthalmology
Physical Medicine and Rehabilitation
Preventive Medicine
Plastic Surgery
Psychiatry and Neurology
Radiology
Urology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
Describe modern paradigms that reduce overdiagnosis and overtreatment in prostate cancer screening, including MRI-based biopsy triage and active surveillance for low-risk disease
Interpret PSA values in the clinical context of prostate size, benign prostatic hyperplasia (BPH), and other benign causes of PSA elevation to guide appropriate evaluation and referral
Summarize updated evidence from major prostate cancer screening trials, including the risks and benefits of screening
Apply practical strategies to communicate the risks and benefits of prostate cancer screening and management options, including active surveillance, with patients
Competencies
Interpersonal & Communication Skills, Medical Knowledge, Patient Care & Procedural Skills, Practice-based Learning & Improvement
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Academic Medicine, Inpatient, Outpatient, Physician Executives, Physician Scientists, Rural, Urban, VA/Military
